Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Impact on brown adipose tissue: Berberine may lower weight by increasing brown adipose tissue, a type of fat tissue that ...

They are doing it not primarily for weight loss — the effect that has made Ozempic a Hollywood staple ... injecting the regular introductory weekly dose, people are only taking half that amount ...

Novo Nordisk shares tumbled last year when obesity candidate CagriSema failed to clear a weight loss bar of 25%. Now, ...

Among those who adhered to treatment, the high-dose group achieved an average weight loss of 20.7% ... semaglutide products – Ozempic and Rybelsus for type 2 diabetes – have been included ...